Prescription drug · ANDA
Enoxaparin Sodium NDC 72572-280
Enoxaparin sodium 100 mg/mL · Injection · Subcutaneous · Civica, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72572-280-10 | 7257202801072572028010 | 10 SYRINGE in 1 CARTON (72572-280-10) / .4 mL in 1 SYRINGE (72572-280-01)Marketed from Nov 1, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Enoxaparin Sodium
- Generic name (nonproprietary)
- enoxaparin sodium
- Active ingredients
- Enoxaparin sodium — 100 mg/mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Labeler
- Civica, Inc.NDC labeler code 72572
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 078990
- Marketing start
- Listing expires
- Other FDA classes
- Low-Molecular-Weight (Chemical structure)
- Identifiers
- Product ID 72572-280_4250f056-1448-49d9-9e27-3751efbfef7aSPL ID 4250f056-1448-49d9-9e27-3751efbfef7a
- Pharmacologic class
- Low Molecular Weight Heparin
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N472572028010followed by a unit qualifier and the quantityPackage 72572-0280-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 72572-280
- What is NDC 72572-280?
- 72572-280 is the product NDC for Enoxaparin Sodium, Enoxaparin sodium 100 mg/mL injection, listed with the FDA by Civica, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Enoxaparin Sodium.
- What is the active ingredient?
- Enoxaparin sodium.
- Who is the labeler?
- Civica, Inc., NDC labeler code 72572. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Enoxaparin Sodium?
- 140 other product NDCs are listed under this name. See all Enoxaparin Sodium NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Enoxaparin Sodium products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| enoxaparin sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | Hebei Changshan Biochemical Pharmaceutical Co., Ltd. | 28955-107 | 28955-0107-10 |
| enoxaparin sodium | Enoxaparin sodium 80 mg/.8mL | InjectionSubcutaneous | Hebei Changshan Biochemical Pharmaceutical Co., Ltd. | 28955-104 | 28955-0104-10 |
| enoxaparin sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Hebei Changshan Biochemical Pharmaceutical Co., Ltd. | 28955-105 | 28955-0105-10 |
| enoxaparin sodium | Enoxaparin sodium 120 mg/.8mL | InjectionSubcutaneous | Hebei Changshan Biochemical Pharmaceutical Co., Ltd. | 28955-106 | 28955-0106-10 |
| enoxaparin sodium | Enoxaparin sodium 60 mg/.6mL | InjectionSubcutaneous | Hebei Changshan Biochemical Pharmaceutical Co., Ltd. | 28955-103 | 28955-0103-10 |
| enoxaparin sodium | Enoxaparin sodium 30 mg/.3mL | InjectionSubcutaneous | Hebei Changshan Biochemical Pharmaceutical Co., Ltd. | 28955-101 | 28955-0101-10 |
| enoxaparin sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | Hebei Changshan Biochemical Pharmaceutical Co., Ltd. | 28955-102 | 28955-0102-10 |
| Enoxaparin Sodium | Enoxaparin sodium 300 mg/3mL | InjectionIntravenous, Subcutaneous | BluePoint Laboratories | 68001-641 | 68001-0641-41 |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | BluePoint Laboratories | 68001-633 | 68001-0633-42 |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | BluePoint Laboratories | 68001-635 | 68001-0635-42 |
Other NDCs under ANDA 078990
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | Sagent Pharmaceuticals | 25021-411 |
| Enoxaparin Sodium | Enoxaparin sodium 30 mg/.3mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-559 |
| Enoxaparin Sodium | Enoxaparin sodium 30 mg/.3mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-559 |
| Enoxaparin Sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-564 |
| Enoxaparin Sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-564 |
| Enoxaparin Sodium | Enoxaparin sodium 60 mg/.6mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-566 |
| Enoxaparin Sodium | Enoxaparin sodium 60 mg/.6mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-566 |
| Enoxaparin Sodium | Enoxaparin sodium 80 mg/.8mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-584 |
| Enoxaparin Sodium | Enoxaparin sodium 80 mg/.8mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-584 |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-586 |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-586 |
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-589 |
| Enoxaparin Sodium | Enoxaparin sodium 30 mg/.3mL | InjectionSubcutaneous | Gland Pharma Limited | 68083-634 |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Gland Pharma Limited | 68083-638 |
| Enoxaparin Sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | Gland Pharma Limited | 68083-635 |
| Enoxaparin Sodium | Enoxaparin sodium 60 mg/.6mL | InjectionSubcutaneous | Gland Pharma Limited | 68083-636 |
| Enoxaparin Sodium | Enoxaparin sodium 80 mg/.8mL | InjectionSubcutaneous | Gland Pharma Limited | 68083-637 |
| Enoxaparin Sodium | Enoxaparin sodium 120 mg/.8mL | InjectionSubcutaneous | Gland Pharma Limited | 68083-639 |
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | Gland Pharma Limited | 68083-640 |
| Enoxaparin Sodium | Enoxaparin sodium 120 mg/.8mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | 63323-655 |
Showing 20 of 22.